Device-specific quality of life: results from the ATLAS trial—avoid transvenous leads in appropriate subjects.

Aims Patient-reported outcomes (PROs) provide important insights into patients' acceptance of their medical devices. Avoid Transvenous Leads in Appropriate Subjects (ATLAS), a randomized, multi-centre, open-label clinical trial, recently reported fewer perioperative complications in subcutaneous imp...

Full description

Bibliographic Details

Published in:	European Journal of Cardiovascular Nursing Vol. 23; no. 8; pp. 877 - 886
Main Authors:	Carroll, Sandra L, Mondésert, Blandine, Krahn, Andrew D, Bashir, Jamil G, Fisher, Kathryn, Nair, Kalpana, Healey, Jeff S
Format:	pictorial research tables/charts Journal Article
Published:	Oxford University Press / USA Nov2024
Online Access:	View this record in EBSCOhost